Position in FLGT
as of Jun 30, 2026
· filed Sep 2, 2026
Position Value
$3,171,920
+$279,361 QoQ
Shares Held
154,577
-15.0% QoQ
Ownership
0.562%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 142 holders
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FLGT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Allianz Asset Management GmbH holds $665,369,236 across 21 Diagnostics & Research names. FLGT ranks #19 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
526,918 | $264,175,606 | |
| 2 | IQV |
Iqvia Holdings Inc.
|
563,844 | $108,945,936 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
145,168 | $76,422,240 | |
| 4 | A |
Agilent Technologies, Inc.
|
400,557 | $53,205,984 | |
| 5 | LH |
Labcorp Holdings Inc.
|
128,335 | $35,933,800 | |
| 6 | CSTL |
Castle Biosciences Inc
|
879,258 | $20,970,302 | |
| 7 | GH |
Guardant Health, Inc.
|
109,240 | $16,389,277 | |
| 8 | DHR |
Danaher Corp /De/
|
65,286 | $12,435,677 |
All Filings in FLGT
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,171,920 | 154,577 | Shares | Defined | 2026-09-02 | |
| 2026-03-31 | $2,892,559 | 181,922 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $3,506,361 | 133,474 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $2,053,639 | 90,869 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $822,713 | 41,384 | Shares | Defined | 2025-07-28 | |
| 2021-09-30 | $286,670 | 3,187 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $681,948 | 7,394 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $912,092 | 9,440 | Shares | Defined | 2021-05-13 | |
| 2020-03-31 | $274,864 | 25,545 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||